Peptides for use in treatment and diagnosis of type 1 diabetes
US10473647B1 · kind B1 · utility
2Cited by
32References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 20, 2015 |
| Grant date | Nov 12, 2019 |
| Priority date | — |
| Expiry date | Feb 7, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are compositions and methods for treating autoimmune diabetes such as type 1 diabetes (T1D), diagnosing autoimmune diabetes such as T1D, assessing treatment efficacy, and selecting subjects for treatment, e.g., using a peptide or epitope disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.